United Therapeutics | UTHR - Trade Debtors


United Therapeutics reported $297.7M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Amarin USD 127.31M 8.18M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Baxter International USD 1.77B 127M Jun/2025
Bayer EUR 14.91B 2.73B Sep/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 790.27M 65.59M Sep/2025
Gilead Sciences USD 5.1B 314M Sep/2025
GlaxoSmithKline GBP 8.3B 607M Sep/2025
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Insmed USD 65.26M 10.23M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
J&J USD 17.61B 235M Sep/2025
Moderna USD 1.05B 589M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Sarepta Therapeutics USD 395.74M 213.86M Sep/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
United Therapeutics USD 297.7M 81.6M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025